Researchers found the PHGDH gene directly causes Alzheimer’s and discovered a drug-like molecule, NCT-503, that may help ...

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

There are currently two main theories about what causes Alzheimer’s. The first theory, which has been the focus of research ...

The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...

Improvements in diagnostics for the early detection of Alzheimer's disease have the potential to transform patient care and ...

Dementia can have a range of causes, such as brain injuries or diseases. Sometimes the cause is unknown. According to the Alzheimer’s Association, Alzheimer’s disease accounts for 60% to 80% ...

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...

May 8, 2025 — The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year ... a condition that causes lower oxygen levels during sleep, is linked to ...

Vaccines seem like an improbable way to reduce the risk of developing dementia. And yet the research has been accumulating to ...